Arcadia Biosciences, Inc.
RKDA
$1.12
$0.076.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.34M | -5.07M | -7.54M | -2.02M | -7.04M |
| Total Depreciation and Amortization | 154.00K | 323.00K | 473.00K | 654.00K | 765.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.53M | -342.00K | 1.55M | -5.09M | -1.91M |
| Change in Net Operating Assets | -26.00K | -1.00M | -2.07M | -1.55M | -1.45M |
| Cash from Operations | -4.74M | -6.09M | -7.58M | -8.01M | -9.63M |
| Capital Expenditure | -- | 0.00 | 0.00 | -3.00K | -16.00K |
| Sale of Property, Plant, and Equipment | -- | -8.00K | 172.00K | 317.00K | 334.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 750.00K | 3.27M | 3.27M | 7.52M | 7.02M |
| Cash from Investing | 750.00K | 3.27M | 3.45M | 7.84M | 7.34M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6.00K | 6.00K | 9.00K | 9.00K | 9.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6.00K | 6.00K | 9.00K | 9.00K | 9.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.98M | -2.82M | -4.13M | -158.00K | -2.28M |